8-K - Catalyst Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events On October 1, 2025, the Company issued a press release announcing that its Board of Directors has approved a share repurchase program authorizing t

Other Event

$200.0M

9.01

Financial Statements and Exhibits. (d) Exhibits 99.1 Press release issued by the Company on October 1, 2025 104 Cover Page Interactive Data File (embedded withi

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1